Cambridge Nutritional Foods has launched PortionIQ, a portion-controlled nutrition range designed for people using GLP-1 weight-loss medications and health-conscious consumers seeking convenient, balanced servings.
PortionIQ blends evidence-based science with real-life practicality in a range of shakes, bites, soups and drinks formulated to help maintain balanced nutrition when appetite is reduced.
Research shows appetite-suppressing medications are on the rise, with 1.6 million adults taking Ozempic, Wegovy and Mounjaro between early 2024 and early 2025 and a further 3.3 million considering using them in the next year.
Mark Gilbert, nutritionist at PortionIQ said, “We’re seeing a real shift in how people approach weight management, particularly with the rising popularity and availability of GLP-1s. But while appetite may decrease while taking these medications, nutritional needs don’t.
“PortionIQ has been developed to bridge that gap – providing balanced protein, fibre and micronutrients in convenient, pre-portioned servings that work in real life. It’s about helping people feel confident they’re nourishing their bodies properly, even when their appetite is reduced.”
Cambridge Nutritional Foods is an employee-owned nutrition company, grounded in trusted science, shared ownership and responsible action. It aims to shape the future of nutrition by serving a high standard for evidence-based health, helping people live healthier, better lives.
In addition to PortionIQ, Cambridge Nutritional Foods’ portfolio includes The 1:1 Diet, a market leader in weight management; Serenova, a women’s wellness supplement brand, and Food Nutrition Partners, its manufacturing and innovation arm.